Wearable Devices Secures $750,000 Grant for Clinical Study of Neural Wristband in Rehabilitation
TL;DR
Wearable Devices gains a $750,000 grant for a clinical pilot, potentially establishing its Mudra Link as a leading rehabilitation tool and creating a competitive edge in the medical tech market.
The clinical pilot will use Wearable Devices' patented surface EMG technology in the Mudra Link wristband to quantitatively monitor neuro-muscular activity for grip-force control rehabilitation.
This technology aims to improve accessibility and outcomes in therapy for patients with motor-cortex injuries, making rehabilitation more effective and enhancing their quality of life.
A wristband that reads muscle signals is being tested to help patients regain hand control, blending AI wearables with advanced medical rehabilitation.
Found this article helpful?
Share it with your network and spread the knowledge!
The Israel Innovation Authority has approved a $750,000 budget to support a clinical pilot study by Wearable Devices Ltd. (NASDAQ: WLDS) with Soroka University Medical Center. This study will evaluate the company's Mudra Link neural wristband as a rehabilitation tool for patients with impaired grip-force control following motor-cortex injuries. This initiative extends the platform's patented surface electromyography (EMG) technology into quantitative neuro-muscular monitoring, aiming to improve accessibility, tracking, and outcomes in force-control therapy.
The company specializes in AI-powered touchless sensing wearables that pioneer human-computer interaction through neural input technology. Its consumer products, the Mudra Band and Mudra Link, enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. By leveraging proprietary sensors, software, and advanced AI algorithms, these devices are defining the neural input category for both wrist-worn devices and brain-computer interfaces. This clinical pilot represents a significant expansion of Wearable Devices' technology into the healthcare sector, specifically targeting rehabilitation for patients recovering from neurological injuries.
The Mudra Link's ability to monitor neuro-muscular activity quantitatively could provide therapists with objective data to track patient progress and tailor rehabilitation programs more effectively. The company operates through a dual-channel model of direct-to-consumer sales and enterprise licensing, with applications ranging from gaming and productivity to extended reality environments. The Israel Innovation Authority's support underscores the potential impact of this technology on rehabilitation medicine. By applying neural input technology to clinical settings, Wearable Devices aims to address challenges in accessibility and outcome measurement for patients undergoing force-control therapy.
The company's ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols "WLDS" and "WLDSW," respectively. Additional information about the company is available through its newsroom at https://ibn.fm/WLDS. This development positions Wearable Devices at the intersection of wearable technology and clinical rehabilitation, potentially setting new standards for how neurological recovery is monitored and supported. The integration of surface EMG technology with AI-powered analysis could transform traditional rehabilitation approaches by providing continuous, objective data that helps both patients and healthcare providers optimize recovery pathways.
Curated from InvestorBrandNetwork (IBN)
